COMMUNIQUÉS West-GlobeNewswire

Stemline Therapeutics Highlights Recent Clinical and Regulatory Developments and Details Upcoming Milestones following its Annual Shareholder Meeting
08/07/2019
NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, [...]
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/07/2019
WALTHAM Mass. and CRESTWOOD, Ky., July 08, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
ICU Medical CFO Announces Intention to Retire from CFO Role After Close of FY19
08/07/2019
SAN CLEMENTE, Calif., July 08, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care [...]
Cronos Group Inc. to Hold Second Quarter 2019 Earnings Conference Call
08/07/2019
TORONTO, July 08, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), will announce its financial results for the second quarter ended June 30, 2019, and hold its [...]
Adamas Announces New Employment Inducement Grant
08/07/2019
EMERYVILLE, Calif., July 08, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted three new employees the [...]
Medexus Pharmaceuticals Announces Operating and Financial Results for Fourth Quarter and Full Fiscal Year Ended March 31, 2019
08/07/2019
Generated $2.4 million of Adjusted EBITDA for fiscal year 2019 Medexus management to host conference call at 4:30 PM ET on July 8, 2019 MONTREAL, July 08, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ [...]
AzurRx BioPharma Announces R&D Update Call on Monday, July 8th at 4:30 PM ET
08/07/2019
NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (AzurRx or the Company), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, [...]
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2019 Financial Results
08/07/2019
Strong Annual Year-Over-Year Growth with 14% Revenue Growth Strong Quarter-Over-Quarter Growth with 20% Revenue Growth and 25% Reduction in Expenses Reduction in Annual Year-Over-Year Net Loss by 18% PETALUMA, Calif., [...]
AzurRx BioPharma Announces Initiation of Phase 2 Clinical Study for MS1819-SD in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency
08/07/2019
Dose escalation study of MS1819-SD in combination with standard porcine pancreatic enzyme replacement therapy (PERT) in CF patients with severe exocrine pancreatic insufficiency (EPI). Patients in study have persistent [...]
Three Genesis HealthCare Centers Earn 2019 Silver National Quality Awards
08/07/2019
KENNETT SQUARE, Pa., July 08, 2019 (GLOBE NEWSWIRE) -- Genesis HealthCare, one of the largest post-acute care providers in the United States, today announced that three of its affiliated skilled nursing / senior living [...]
HealthEquity Announces Commencement of Proposed Offering of Common Stock
08/07/2019
DRAPER, Utah, July 08, 2019 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY), the nation’s largest independent health savings account non-bank custodian, today announced that it has commenced an underwritten public [...]
SunGen Pharma Receives Sixth ANDA Approval from US FDA
08/07/2019
PRINCETON, N.J., July 08, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced it [...]
Genmab Announces Positive Topline Results in the Phase II GRIFFIN Study of Transplant Eligible, Newly Diagnosed Patients with Multiple Myeloma Treated with Daratumumab in Combination with Lenalidomide, Bortezomib, and Dexamethasone
08/07/2019
Company Announcement Topline data from the randomized Phase II GRIFFIN study in transplant eligible, newly diagnosed patients with multiple myeloma treated with daratumumab in combination with lenalidomide, bortezomib, [...]
Cerner Announces New Chief Human Resources Officer
08/07/2019
Medtronic veteran to join the health care technology company KANSAS CITY, Mo., July 08, 2019 (GLOBE NEWSWIRE) -- Cerner (NASDAQ: CERN), a global health platform and innovation company, announced today that Tracy Platt [...]
Ossur hf: Transactions in relation to share buyback program
08/07/2019
Announcement no. 40/2019 8 July 2019 Transactions in relation to share buyback program On 14 May 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 31/2019. The purpose of the share buyback [...]
AVRA Medical Robotics Announces its Participation in 10th Annual Meeting of the Society of Robotic Surgery
08/07/2019
ORLANDO, Fla., July 08, 2019 (GLOBE NEWSWIRE) -- AVRA Medical Robotics, Inc. (the “Company”) (OTCQB: AVMR), an emerging company developing a proprietary software coded system that uses artificial intelligence and [...]
RAFARMA’s Blockchain Tech Ready for Thailand’s Approved Uses of Cannabis
08/07/2019
Ljubljana, Slovenia, July 08, 2019 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. (OTC: RAFA), is pleased to announce the commencement of negotiations with the government of the Kingdom of Thailand to use the company [...]
Athersys to Host Second Quarter Financial Results Call
08/07/2019
CLEVELAND, July 08, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) will release its second quarter 2019 financial results at approximately 4:00 PM Eastern Time on Wednesday, August 7, 2019, and will host a [...]
Medtronic HeartWare(TM) HVAD(TM) Implanted via Less Invasive Thoracotomy Shows 95 Percent Freedom from Disabling Stroke at Two Years
08/07/2019
Company Plans Global Registry of HVAD Thoracotomy Implants to Advance Therapy Knowledge DUBLIN, July 08, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced two-year outcomes from the LATERAL clinical [...]

Pages